Authors:
LEYVRAZ S
PEREY L
ROSTI G
LANGE A
PAMPALLONA S
PASINI F
BOSQUEE L
HUMBLET Y
MARANGOLO M
Citation: S. Leyvraz et al., SEQUENTIAL HIGH-DOSE CHEMOTHERAPY FOR SMALL-CELL LUNG-CANCER - AN EBMT PHASE-II STUDY, Annals of oncology, 9, 1998, pp. 406-406
Authors:
LEYVRAZ S
PEREY L
ROSTI G
LANGE A
PAMPALLONA S
PASINI F
BOSQUEE L
HUMBLET Y
MARANGOLO M
Citation: S. Leyvraz et al., HIGH-DOSE CHEMOTHERAPY FOR SMALL-CELL LUNG-CANCER - FINAL RESULTS OF THE EBMT PHASE-II STUDY, Bone marrow transplantation, 21, 1998, pp. 800-800
Authors:
NOIRHOMME P
DUDEKEM Y
MUNTING E
ELKHOURY G
HUMBLET Y
DION RA
Citation: P. Noirhomme et al., RESECTION OF A CHEST CHONDROSARCOMA INVADING THE SPINE AND THE AORTA, The Annals of thoracic surgery, 65(2), 1998, pp. 534-535
Authors:
DHONDT L
ANDRE M
GUILLAUME T
FEYENS AM
HUMBLET Y
DOYEN C
BOSLY A
DROMELET A
CHATELAIN B
SYMANN M
Citation: L. Dhondt et al., QUANTIFICATION OF CD34(-BLOOD PREDICTS THE YIELD OF THE LEUKAPHERESISPRODUCT AND CAN REPLACE PROGENITOR ASSAYS() CELLS MOBILIZED INTO THE PERIPHERAL), Cytokines cellular & molecular therapy, 3(1), 1997, pp. 21-26
Authors:
CATY A
OUDARD S
HUMBLET Y
BEAUDUIN M
SUC E
GIL T
ROLLAND F
HOUYAU P
SUN X
MONTCUQUET P
BREZA J
FAVREAU E
TRESCA P
CHOPIN D
Citation: A. Caty et al., PHASE-II STUDY OF VINORELBINE IN PATIENTS WITH HORMONE-REFRACTORY PROSTATE-CANCER, European journal of cancer, 33, 1997, pp. 135-135
Authors:
BARONE C
POZZO C
STARKHAMMAR H
TERZOLI E
GARUFI C
DIRIX L
HUMBLET Y
COGNETTI F
FAGES B
COTE C
VANCUTSEM E
Citation: C. Barone et al., CPT11 ALTERNATING WITH 5-FLUOROURACIL (5 FU) FOLINIC ACID (FA) - A MULTICENTER PHASE-II STUDY IN 1ST LINE CHEMOTHERAPY (CT) OF METASTATIC COLORECTAL-CANCER (CRC) - PRELIMINARY-RESULTS, European journal of cancer, 33, 1997, pp. 758-758
Authors:
DHONDT L
ANDRE M
CANON JL
GUILLAUME T
DOYEN C
FEYENS AM
CHATELAIN B
DROMELET A
HUMBLET Y
LONGUEVILLE J
SYMANN M
Citation: L. Dhondt et al., EFFICIENCY OF HIGH-DOSE FEC CHEMOTHERAPY FOR MOBILIZING HEMATOPOIETICSTEM-CELLS INTO PERIPHERAL-BLOOD, Bulletin du cancer, 84(7), 1997, pp. 729-733
Authors:
DHONDT L
ANDREE M
WUU J
VANLERBERGHE C
GUILLAUME T
FEYENS AM
DROMELET A
CHATELAIN B
HUMBLET Y
LONGUEVILLE J
SYMANN M
Citation: L. Dhondt et al., THE CLEARANCE OF CD34-BLOOD (PB) AFTER PERIPHERAL-BLOOD HEMATOPOIETICSTEM-CELL (PBHSC) INFUSION IS CORRELATED WITH THE HEMATOLOGIC RECOVERY (HR)( CELLS FROM PERIPHERAL), Blood, 90(10), 1997, pp. 4355-4355
Citation: L. Dhondt et al., DIGITAL NECROSIS ASSOCIATED WITH CHRONIC MYELOID-LEUKEMIA - A RARE PARANEOPLASTIC PHENOMENON ... AND NOT A TOXICITY OF RECOMBINANT INTERFERON, Acta Clinica Belgica, 52(1), 1997, pp. 49-49
Authors:
LONNEUX M
JAMAR F
BAUSART R
SIBOMANA M
LENERS N
HUMBLET Y
COLLARD P
PAUWELS S
Citation: M. Lonneux et al., STAGING OF SMALL-CELL LUNG-CANCER (SCLC) WITH IN-111 PENTETREOTIDE SCINTIGRAPHY - COMPARISON WITH WHOLE-BODY PET-FDG, The Journal of nuclear medicine, 37(10), 1996, pp. 1817-1817
Authors:
PUNT CJA
HUMBLET Y
ROCA E
DIRIX LY
WAINSTEIN R
POLLI A
CORRADINO I
Citation: Cja. Punt et al., TALLIMUSTINE IN ADVANCED PREVIOUSLY UNTREATED COLORECTAL-CANCER, A PHASE-II STUDY, British Journal of Cancer, 73(6), 1996, pp. 803-804
Authors:
DHONDT L
ANDRE M
DUPRET P
GUILLAUME T
FEYENS AM
DROMELET A
CHATELAIN B
HUMBLET Y
LONGUEVILLE J
SYMANN M
Citation: L. Dhondt et al., CORRELATION BETWEEN THE RAPIDITY OF CLEARANCE OF CD34(-BLOOD AND HEMATOLOGIC RECOVERY FOLLOWING AUTOLOGOUS HEMATOPOIETIC STEM-CELLS INFUSION() CELLS FROM THE PERIPHERAL), Blood, 88(10), 1996, pp. 3740-3740
Authors:
DHONDT L
FILLEUL B
GUILLAUME T
HUMBLET Y
LONGUEVILLE J
WILLOCX R
SYMANN M
Citation: L. Dhondt et al., SEVERE ANAL CONDYLOMATA ACUMINATA FOLLOWING HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS HEMATOPOIETIC STEM-CELL TRANSPLANTATION - A CASE-REPORT, Acta Gastro-Enterologica Belgica, 59(4), 1996, pp. 254-255
Authors:
LEYVRAZ S
LANGE A
PEREY L
KETTERER N
BOSQUEE L
ROSTI G
PASINI F
HAMDAN O
HUMBLET Y
CETTO GL
MARANGOLO M
Citation: S. Leyvraz et al., HIGH-DOSE SEQUENTIAL CHEMOTHERAPY (ICE) UNDER CIRCULATING PROGENITOR CELLS (CPC) PROTECTION IN PATIENTS WITH SMALL-CELL LUNG-CARCINOMA (SCLC) - PRELIMINARY-REPORT ON A MULTICENTRIC STUDY, European journal of cancer, 31A, 1995, pp. 90-90
Authors:
DHONDT L
ANDRE M
GUILLAUME T
FEYENS AM
CANON JL
DOYEN C
HUMBLET Y
LONGUEVILLE J
VANNEROM H
SYMANN M
Citation: L. Dhondt et al., A RANDOMIZED PILOT CLINICAL-TRIAL COMPARING 5 VERSUS 10 MU-G KG FILGRASTIM (NEUPOGEN) AFTER FEC CHEMOTHERAPY IN ORDER TO COLLECT PERIPHERAL-BLOOD STEM-CELLS (PBSC)/, European journal of cancer, 31A, 1995, pp. 355-355
Authors:
DHONDT L
DUPRET PH
ANDRE M
GUILLAUME TH
FEVENS AM
HUMBLET Y
DROMELET A
CHATELAIN B
LONGUEVILLE J
SYMANN M
Citation: L. Dhondt et al., CIRCULATING CD34-DOSE CHEMOTHERAPY AND AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELLS( CELL LEVELS DETERMINED 30 MINUTES FOLLOWING INFUSION PREDICTHEMATOLOGIC RECOVERY AFTER HIGH), Experimental hematology, 23(8), 1995, pp. 754-754
Authors:
MARCHAND M
WEYNANTS P
RANKIN E
ARIENTI F
BELLI F
PARMIANI G
CASCINELLI N
BOURLOND A
VANWIJCK R
HUMBLET Y
CANON JL
LAURENT C
NAEYAERT JM
PLAGNE R
DERAEMAEKER R
KNUTH A
JAGER E
BRASSEUR F
HERMAN J
COULIE PG
BOON T
Citation: M. Marchand et al., TUMOR-REGRESSION RESPONSES IN MELANOMA PATIENTS TREATED WITH A PEPTIDE ENCODED BY GENE MAGE-3, International journal of cancer, 63(6), 1995, pp. 883-885
Authors:
BRASSEUR F
RIMOLDI D
LIENARD D
LETHE B
CARREL S
ARIENTI F
SUTER L
VANWIJCK R
BOURLOND A
HUMBLET Y
VACCA A
CONESE M
LAHAYE T
DEGIOVANNI G
DERAEMAECKER R
BEAUDUIN M
SASTRE X
SALAMON E
DRENO B
JAGER E
KNUTH A
CHEVREAU C
SUCIU S
LACHAPELLE JM
POUILLART P
PARMIANI G
LEJEUNE F
CEROTTINI JC
BOON T
MARCHAND M
Citation: F. Brasseur et al., EXPRESSION OF MAGE GENES IN PRIMARY AND METASTATIC CUTANEOUS MELANOMA, International journal of cancer, 63(3), 1995, pp. 375-380
Authors:
DHONDT V
HUMBLET Y
GUILLAUME T
BAATOUT S
CHATELAIN C
BERLIERE M
LONGUEVILLE J
FEYENS AM
DEGREVE J
VANOOSTEROM A
VONGRAFFENRIED B
DONNEZ J
SYMANN M
Citation: V. Dhondt et al., THROMBOPOIETIC EFFECTS AND TOXICITY OF INTERLEUKIN-6 IN PATIENTS WITHOVARIAN-CANCER BEFORE AND AFTER CHEMOTHERAPY - A MULTICENTRIC PLACEBO-CONTROLLED, RANDOMIZED PHASE IB STUDY, Blood, 85(9), 1995, pp. 2347-2353
Authors:
DHONDT L
GUILLAUME T
HUMBLET Y
MORIAU M
LACHAPELLE JM
SYMANN M
Citation: L. Dhondt et al., DIGITAL NECROSIS ASSOCIATED WITH CHRONIC MYELOID-LEUKEMIA - A RARE PARANEOPLASTIC PHENOMENON, Acta Clinica Belgica, 50(5), 1995, pp. 297-300
Authors:
DHONDT V
GUILLAUME T
HUMBLET Y
DOYEN C
CHATELAIN B
FEYENS AM
STAQUET P
OSSELAER JC
MULL B
SYMANN M
Citation: V. Dhondt et al., TOLERANCE OF SEQUENTIAL OR SIMULTANEOUS ADMINISTRATION OF IL-3 AND G-CSF IN IMPROVING PERIPHERAL-BLOOD STEM-CELLS HARVESTING FOLLOWING MULTIAGENT CHEMOTHERAPY - A PILOT-STUDY, Bone marrow transplantation, 13(3), 1994, pp. 261-264
Authors:
DHONDT V
WEYNANTS P
HUMBLET Y
GUILLAUME T
CANON JL
BEAUDUIN M
DUPREZ P
LONGUEVILLE J
MULL R
CHATELAIN C
SYMANN M
Citation: V. Dhondt et al., DOSE-DEPENDENT INTERLEUKIN-3 STIMULATION OF THROMBOPOIESIS AND NEUTROPOIESIS IN PATIENTS WITH SMALL-CELL LUNG-CARCINOMA BEFORE AND FOLLOWING CHEMOTHERAPY - A PLACEBO-CONTROLLED RANDOMIZED PHASE-IB STUDY, Journal of clinical oncology, 11(11), 1993, pp. 2063-2071